Abstract

BackgroundLet-7a is a small non-coding RNA that has been found to take part in cell proliferation and apoptosis. The hippo-YAP1 axis, known as a tumour suppressor pathway, also plays an important role in cell proliferation and apoptosis. YAP1, TAZ, and phospho-YAP1 play key roles in actions of the hippo-YAP1 axis. Adenomyosis (ADS) is a proliferative disease leading to a large uterus in patients with prolonged illness. Abnormal proliferation of smooth muscle cells (SMCs) in the uterine endometrial-myometrial junctional zone (JZ) is an important reason for developing ADS. This study aimed to explore the expression levels of let-7a and components of the hippo-YAP1 axis in SMCs in the uterine endometrial-myometrial JZ in ADS and to explore the roles of let-7a and the hippo-YAP1 axis of JZ SMC proliferation and apoptosis in ADS.MethodsWe collected JZ tissues for the primary culture of SMCs from 25 women diagnosed with ADS and 27 women without ADS. We used quantitative real-time polymerase chain reaction and western blotting to measure the mRNA and protein expression levels of let-7a, YAP1, TAZ, and phospho-YAP1 in ADS JZ SMCs. A CCK-8 assay and flow cytometry analysis of apoptosis were utilized to test the proliferation and apoptosis of JZ SMCs. The let-7a overexpression lentiviral vector GV280 was used to increase the expression level of let-7a. We added verteporfin to block the phosphorylation of components of the hippo-YAP1 axis.ResultsWe found that the let-7a level was decreased, while the YAP1 and TAZ levels were increased in ADS JZ SMCs. Upregulated let-7a affected the expression levels of components of the hippo-YAP1 axis, accelerated apoptosis, and inhibited proliferation in JZ SMCs. Furthermore, accumulated YAP1 led to increasing proliferation of JZ SMCs after verteporfin treatment to block the phosphorylation of components of the hippo-YAP1 axis. If components of the hippo-YAP1 axis were unphosphorylated, upregulated let-7a could not inhibit the proliferation of ADS JZ SMCs. Upregulated let-7a could not activate the hippo-YAP1 axis in verteporfin treatment.ConclusionsOur findings suggest that the let-7a and hippo-YAP1 axis may act as important regulators of JZ SMCs proliferation, and upregulated let-7a may be an effective method to treat ADS.

Highlights

  • Let-7a is a small non-coding RNA that has been found to take part in cell proliferation and apoptosis

  • Our findings suggest that the let-7a and hippo-YAP1 axis may act as important regulators of junctional zone (JZ) smooth muscle cells (SMCs) proliferation, and upregulated let-7a may be an effective method to treat ADS

  • Verteporfin inhibits the phosphorylation of YAP1, leading to an elevated proliferation of JZ SMCs Because phosphorylated YAP1 plays a key role in the Hippo-YAP kinase cascade axis and we found that YAP1 is upregulated in JZ SMCs, we used verteporfin to block the phosphorylation of YAP1 and detected the role of YAP1 in SMCs

Read more

Summary

Introduction

Let-7a is a small non-coding RNA that has been found to take part in cell proliferation and apoptosis. The hippo-YAP1 axis, known as a tumour suppressor pathway, plays an important role in cell proliferation and apoptosis. Abnormal proliferation of smooth muscle cells (SMCs) in the uterine endometrial-myometrial junctional zone (JZ) is an important reason for developing ADS. Progressive dysmenorrhea, and infertility are the major causes that drive patients with ADS to seek treatments [1]. This disease has been known for many years, its pathogenesis is still unclear. The endometrial-myometrial junctional zone (JZ) plays an important role in the development of ADS Irregular thickening of this zone greater than 12 mm on T2weighted magnetic resonance imaging has become the key criterion in the diagnosis of ADS [2].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call